)
Integra LifeSciences (IART) investor relations material
Integra LifeSciences Citi Annual Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Leadership insights and operational challenges
New leadership highlighted the strength and brand equity of the portfolio, with positive customer feedback on product value.
Operational and execution challenges were deeper than anticipated, prompting a focus on transforming quality management systems and supply chain operations.
Team resilience enabled rapid product relaunches and productivity improvements, especially for Integra Skin, PriMatrix, and Durepair.
Harmonizing quality management systems globally became a key lesson, leading to the Compliance Master Plan initiated in mid-2024.
Commercial integration post-acquisitions was strong, but supply chain and quality systems required further harmonization.
Facility updates and supply chain initiatives
The new Braintree manufacturing facility is on track to be operational by June 2026, with ongoing equipment validation and documentation.
The older facility has already been closed, with all employees transitioned to Braintree.
Dual sourcing and third-party partnerships enabled early relaunches of PriMatrix and Durepair, nearly a year ahead of schedule.
Early feedback on relaunched products has been positive, with customers expressing strong preference for their unique properties.
Supply chain optimization and quality management remain central to meeting strong product demand and stabilizing operations.
Portfolio strategy and growth focus
A comprehensive portfolio review was conducted to align capital allocation with long-term value creation.
Growth priorities include implant-based breast reconstruction (IBBR), tissue technology, and wound care, with PMA strategies for SurgiMend and DuraSorb.
The IBBR market is estimated at $800 million, growing at high single to low double digits, with significant share capture opportunities post-PMA.
Launches for the next year include full-year relaunches of PriMatrix and Durepair, SurgiMend 510(k) in Q4, and a new Acclarent product.
CMS payment changes are expected to provide significant upside for tissue technology products.
Next Integra LifeSciences earnings date
Next Integra LifeSciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)